[Effects of infusion treatment once a day for 4 weeks with alprostadil-alpha-cyclodextrin on blood levels of endothelin-1 in patients with chronic obliterative arteriopathy of the legs at Leriche-Fontaine stage 2].
Mangiafico
R A
RA
Istituto di Clinica Medica L. Condorelli, Università degli Studi, Catania.
Malatino
L S
LS
Attinà
T
T
Dell'Arte
S
S
Messina
R
R
D000527:Alprostadil / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001157:Arterial Occlusive Diseases / Q000097:blood* / Q000188:drug therapy*; D002908:Chronic Disease; D003505:Cyclodextrins / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D019332:Endothelin-1 / Q000097:blood*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007866:Leg / Q000098:blood supply*; D016491:Peripheral Vascular Diseases / Q000097:blood* / Q000209:etiology*; D047391:alpha-Cyclodextrins
D003505:Cyclodextrins; D019332:Endothelin-1; D047391:alpha-Cyclodextrins; C043214:prostaglandin E1-alpha-cyclodextrin; D000527:Alprostadil